Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.57 - $3.33 $107,709 - $228,454
-68,605 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.76 - $4.64 $386 - $649
140 Added 0.2%
68,605 $221,000
Q4 2021

Feb 14, 2022

BUY
$4.09 - $7.16 $14,875 - $26,040
3,637 Added 5.61%
68,465 $295,000
Q3 2021

Nov 12, 2021

SELL
$5.8 - $8.02 $25,763 - $35,624
-4,442 Reduced 6.41%
64,828 $387,000
Q2 2021

Aug 16, 2021

SELL
$6.87 - $9.16 $457,383 - $609,845
-66,577 Reduced 49.01%
69,270 $574,000
Q1 2021

May 14, 2021

BUY
$7.67 - $13.77 $498,434 - $894,843
64,985 Added 91.71%
135,847 $1.17 Million
Q4 2020

Feb 12, 2021

BUY
$12.07 - $17.95 $182,039 - $270,721
15,082 Added 27.04%
70,862 $858,000
Q3 2020

Nov 13, 2020

BUY
$14.16 - $19.45 $86,899 - $119,364
6,137 Added 12.36%
55,780 $906,000
Q2 2020

Aug 12, 2020

BUY
$6.97 - $17.12 $346,011 - $849,888
49,643 New
49,643 $746,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $132M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.